Yahoo
Shanghai - Delayed Quote CNY

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS)

15.46 +0.18 (+1.18%)
At close: 3:00:01 PM GMT+8
Dividend
603858.SS announced a cash dividend of CNY 0.48 with an ex-date of Nov. 5, 2026
Chart Range Bar
Loading chart for 603858.SS
  • Previous Close 15.28
  • Open 15.25
  • Bid 15.46 x --
  • Ask 15.47 x --
  • Day's Range 15.21 - 15.51
  • 52 Week Range 14.01 - 18.47
  • Volume 6,734,653
  • Avg. Volume 5,339,839
  • Market Cap (intraday) 16.304B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 55.21
  • EPS (TTM) 0.28
  • Earnings Date --
  • Forward Dividend & Yield 0.57 (3.73%)
  • Ex-Dividend Date Nov 5, 2026
  • 1y Target Est --

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicines in China and internationally. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.

www.buchang.com

7,237

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

603858.SS
0.00%
SSE Composite Index (000001.SS)
9.09%

1-Year Return

603858.SS
9.18%
SSE Composite Index (000001.SS)
9.26%

3-Year Return

603858.SS
6.36%
SSE Composite Index (000001.SS)
19.05%

5-Year Return

603858.SS
3.36%
SSE Composite Index (000001.SS)
3.13%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    0.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: